Treat-to-Target IBD

Biologic therapy guided to mucosal healing — STRIDE-II targets & tight biomarker control in Crohn's disease & ulcerative colitis

Current Stage

—

CRP (mg/L)

—

Fecal Calpro (μg/g)

—

Endoscopic Score

—

2-Yr Relapse/Surg Risk

—

Monitoring StrategySymptom-Guided

Time ElapsedWeek 0

Active ulceration / erosion

Neutrophil / immune infiltrate

Healed epithelium / crypts

Anti-TNF / biologic antibody

Biomarker sensor / calprotectin